SherazMarkar United Kingdom

• ROBOTIC ESOPHAGECTOMY–TRANS-THORACIC WITH VARIOUS ANASTOMOSES
  115-1
  Markvan Berge Henegouwen Speaker Netherlands
• MINIMALLY-INVASIVE MCKEOWN ESOPHAGECTOMY
  115-2
  HirotoshiKikuchi Speaker Japan
• OPEN LEFT THORACO-ABDOMINAL ESOPHAGOGASTRECTOMY: INDICATIONS AND SEVERAL ALTERNATE CONDUITS AND WHEN TO USE THEM (E.G. PEDICLED JEJUNAL INTERPOSITION, GASTRIC CONDUIT, COLON)
  115-3
  Lorenzo E.Ferri Speaker Canada
• MINIMALLY INVASIVE SUBTOTAL GASTROECTOMY WITH D2 LYPHADENECTOMY DEMONSTRATING SEVERAL ANASTOMOTIC TECHNIQUES
  115-4
  Masashi Yoshida Speaker Japan
• RE-OPERATIVE SURGERY AFTER THE FAILED FUNDOPLICATION
  115-5
  ItaloBraghetto Speaker Chile
• LAPAROSCOPIC REPAIR OF PARAESOPHAGEAL HERNIA
  115-6
  John G. Hunter Speaker United States

• UPPER GI - ESOPHAGEAL CANCER WITH CLINICAL COMPLETE RESPONSE POST CHEMORADIATION
  EARLY ELECTIVE SURGERY
  216-1
  SherazMarkar Speaker United Kingdom
• UPPER GI - ESOPHAGEAL CANCER WITH CLINICAL COMPLETE RESPONSE POST CHEMORADIATION
  SURVEILLANCE AND DELAYED SURGERY
  216-2
  Simon Ying-Kit Law Speaker Hong Kong, China
• HPB – NEOADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREAS CANCER
  SURGERY + ADJUVANT THERAPY
  216-3
  Eduardo E. Montalvo Jave Speaker Mexico
• HPB – NEOADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREAS CANCER
  NEOADJUVANT THERAPY
  216-4
  TaylorRiall Speaker United States
• CRC – MANAGEMENT OF RECTAL CANCER WITH COMPLETE CLINICAL RESPONSE AFTER TOTAL NEOADJUVANT THERAPY (TNT) IN THE SETTING OF SYNCHRONOUS OLIGOMETASTATIC LIVER METASTASES — SHOULD THE RECTUM BE LEFT INTACT IF LIVER RESECTION IS PURSUED?
  YES - WHEN IN DOUBT, TAKE IT OUT!
  216-5
  AlessandroFichera Speaker United States
• CRC – MANAGEMENT OF RECTAL CANCER WITH COMPLETE CLINICAL RESPONSE AFTER TOTAL NEOADJUVANT THERAPY (TNT) IN THE SETTING OF SYNCHRONOUS OLIGOMETASTATIC LIVER METASTASES — SHOULD THE RECTUM BE LEFT INTACT IF LIVER RESECTION IS PURSUED?
  LEAVE IT ALONE - PRIMUM NON NOCERE
  216-6

• CURRENT PARADIGM IN MANAGEMENT OF LOCALLY ADVANCED ESOPHAGEAL CANCER
  313-1
  Lorenzo E.Ferri Speaker Canada
• T4B ESOPHAGEAL SQUAMOUS CELL CARCINOMA: PRACTICAL APPROACH TO MANAGEMENT OF BORDERLINE RESECTABLE CANCERS
  313-2
  HirotoshiKikuchi Speaker Japan
• MODERN MANAGEMENT OF GASTRO-ESOPHAGEAL JUNCTIONAL CANCERS: MULTIMODAL THERAPY AND SURGICAL APPROACH
  313-3
  Suzanne S.Gisbertz Speaker Netherlands
• LIMITED METASTASES FROM GASTRO ESOPHAGEAL CANCER: A SURGICAL DISEASE?
  313-4
  SherazMarkar Speaker United Kingdom
• OPTIMIZING PERI-OPERATIVE OUTCOMES FOR THE ESOPHAGEAL CANCER PATIENT
  313-5
  Wayne Hofstetter Speaker United States

• NOVEL ROBOTIC PLATFORMS
  316-1
  James Oh Park Speaker United States
• AI IN SURGERY
  316-2
  JesusTapia Speaker Mexico
• AI AND EXTENDED REALITY: TRANSFORMING SURGICAL EDUCATION
  316-3
  GeraldFried Speaker Canada
• METAVERSE IN SURGERY
  316-4
  MicheleAmmendola Speaker Italy
• MAGNETIC SURGERY
  316-5
  MichelGagner Speaker Canada
• FLUORESCENCE GUIDED UPPER GI SURGERY LYMPHADENECTOMY
  316-6
  Suzanne S.Gisbertz Speaker Netherlands